Adma Biologics Inc

NASDAQ:ADMA   3:59:52 PM EDT
2.04
+0.10 (+5.16%)
Other Pre-Announcement

Adma Biologics Announces Fourth Quarter And Full Year 2021 Financial Results And Provides Business Update, Including $175M Debt Refinance With Hayfin Capital Management

Published: 03/24/2022 20:54 GMT
Adma Biologics Inc (ADMA) - Adma Biologics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update, Including $175m Debt Refinance With Hayfin Capital Management.
Q4 Loss per Share $0.09.
Sees FY Revenue Up 50 Percent.
Sees FY Revenue More Than $125 Million.
Q4 Revenue Rose 89 Percent to $26.4 Million.